•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A08664 Summary:

BILL NOA08664
 
SAME ASSAME AS S08364
 
SPONSORMcDonald
 
COSPNSRWoerner
 
MLTSPNSR
 
Amd 6802 & 6801, Ed L
 
Relates to the administration of reversible progestin-only contraceptive injections; provides that no pharmacist shall administer reversible progestin-only contraceptive injections without receiving training satisfactory to the commissioner of education and the commissioner of health.
Go to top    

A08664 Actions:

BILL NOA08664
 
05/23/2025referred to higher education
05/28/2025reported referred to rules
01/07/2026referred to higher education
Go to top

A08664 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
 
BILL NUMBER: A8664
 
SPONSOR: McDonald
  TITLE OF BILL: An act to amend the education law, in relation to the administration of reversible progestin-only contraceptive injections   PURPOSE: To authorize pharmacists to administer injections for contraceptive use.   SUMMARY OF PROVISIONS: Section 1 amends subdivision 22 of section 6802 of the education law to include pharmacist administration of reversible progest-in-only contra- ceptive injections approved by the United States Food and Drug Adminis- tration (USFDA) and pursuant to a patient specific prescription or order within the definition of administer. Section 2 amends section 6801 of the education law to include pharmacist administration of reversible prOgestin-only contraceptive injections within the definition of practice of pharmacy and ensure training satis- factory to the department. Section 3 provides the effective date.   JUSTIFICATION: Over 25,000 women throughout New York live in contraceptive deserts, without access to a single clinic with the full range of contraceptives. As a result, some women must cross county lines to receive the contra- ceptive of their choice. With 60% of women of reproductive age currently using a contraceptive method, it is clear that access to contraception is a public health concern. One such shot is the Depo-Provera injection that must be received every three months. In New York, it must be given by your healthcare provider rather than a pharmacist. This is an unnec- essary barrier keeping women from the contraception of their choice. This bill would allow pharmacists to administer these injections, pursu- ant to a patient specific prescription or order, allowing women to receive their hormonal injection at their local pharmacy. Pharmacies are convenient locations for accessing birth control given their preva- lence in communities and their flexible hours. This legislation improves access for marginalized communities of young people, rural communities, and other individuals who have historically experienced barriers to reproductive and contraceptive care.   LEGISLATIVE HISTORY: 2023-2024: A.8881/S.5635A   FISCAL IMPLICATIONS: None.   EFFECTIVE DATE: This act shall take effect on the one hundred eightieth day after it shall have become a law.
Go to top

A08664 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          8664
 
                               2025-2026 Regular Sessions
 
                   IN ASSEMBLY
 
                                      May 23, 2025
                                       ___________
 
        Introduced by M. of A. McDONALD -- read once and referred to the Commit-
          tee on Higher Education
 
        AN  ACT to amend the education law, in relation to the administration of
          reversible progestin-only contraceptive injections
 
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:

     1    Section  1.  Subdivision  22  of  section 6802 of the education law is
     2  amended by adding a new paragraph c to read as follows:
     3    c. The administration of  a  reversible  progestin-only  contraceptive
     4  injection  approved  by  the  U.S.  Food  and  Drug  Administration,  as
     5  prescribed or ordered by a licensed prescriber, acting within the  scope
     6  of  their  practice  in  this  state  and in accordance with regulations
     7  promulgated by the commissioner, provided that:
     8    (1) Such administration is conducted pursuant to a valid  patient-spe-
     9  cific prescription or patient-specific order.
    10    (2)  The  pharmacist  shall  notify  the  licensed prescriber that the
    11  administration is complete within five days and shall convey such infor-
    12  mation to the prescriber by making an entry into an interoperable  elec-
    13  tronic medical records system, an electronic prescribing technology or a
    14  pharmacy record, or by using facsimile, electronic transmission or other
    15  electronic means.  If an electronic means described in this subparagraph
    16  is  not  available  to  the pharmacist at the time of communication, the
    17  pharmacist or pharmacist's designee may communicate the  information  by
    18  telephone.    Notification  shall also be required if a patient does not
    19  receive an administration or if the patient experiences any side effects
    20  or adverse reactions to the medications. Administration  in  a  pharmacy
    21  shall  not  commence  until  after  the patient has received the initial
    22  injection and is considered eligible for maintenance  treatment  by  the
    23  licensed prescriber.
    24    (3)  Such  prescription  may be subject to reassessment at appropriate
    25  intervals, as determined by the licensed prescriber.
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD13237-02-5

        A. 8664                             2
 
     1    (4) When administering an injection  in  a  pharmacy,  the  pharmacist
     2  shall  provide an area for the injection that provides for the patient's
     3  privacy.
     4    § 2. Subdivision 3 of section 6801 of the education law, as amended by
     5  chapter  746 of the laws of 2023, is amended and a new subdivision 10 is
     6  added to read as follows:
     7    3. No pharmacist shall administer immunizing agents  [or],  injectable
     8  medications  for the treatment of mental health and substance use disor-
     9  der, or  reversible  progestin-only  contraceptive  injections,  without
    10  receiving training satisfactory to the commissioner and the commissioner
    11  of  health  which  shall  include, but not be limited to, techniques for
    12  screening individuals and  obtaining  informed  consent;  techniques  of
    13  administration;  indications,  precautions  and contraindications in the
    14  use of agent or agents; record keeping of immunization and  information;
    15  and handling emergencies, including anaphylaxis and needlesticks.
    16    10.  A licensed pharmacist, within their lawful scope of practice, who
    17  holds a certificate of administration  issued  by  the  department,  may
    18  administer  reversible progestin-only contraceptive injections and medi-
    19  cations required for emergency treatment of anaphylaxis related to  such
    20  administration pursuant to section sixty-eight hundred two of this arti-
    21  cle,  as  prescribed  or  ordered by a licensed prescriber acting within
    22  their scope of practice in this state and in accordance with regulations
    23  promulgated by the commissioner.
    24    § 3. This act shall take effect on the one hundred eightieth day after
    25  it shall have become a law. Effective immediately, the addition,  amend-
    26  ment and/or repeal of any rule or regulation necessary for the implemen-
    27  tation  of  this act on its effective date are authorized to be made and
    28  completed on or before such effective date.
Go to top